Literature DB >> 11592835

Functional effect of adeno-associated virus mediated gene transfer of aromatic L-amino acid decarboxylase into the striatum of 6-OHDA-lesioned rats.

R Sánchez-Pernaute1, J Harvey-White, J Cunningham, K S Bankiewicz.   

Abstract

In animal models of Parkinson's disease, gene transfer of aromatic L-amino acid decarboxylase (AADC) leads to an increase in the capacity of the striatum to decarboxylate exogenous L-DOPA. However, the functional effects of enhanced L-DOPA to dopamine conversion have not been explored. Here, we show that following adeno-associated virus (AAV)-AADC transduction, the transgenic AADC is able to decarboxylate exogenous L-DOPA more efficiently so that a dose of L-DOPA ineffective before gene transfer elicits a motor asymmetry (rotational behavior) following gene transfer. Furthermore, rotation scores showed a strong correlation with AADC activity in the lesioned striatum, thus allowing for behavioral screening of successful gene transfer in the brain. In animals receiving AAV2-AADC, dopamine production was restored to 50% of normal levels 12 weeks after the infusion. Microdialysis experiments demonstrated an in vivo enhanced conversion of L-DOPA to dopamine, but no storage capacity as dopamine was released to the extracellular space in a continuous, nonregulated fashion. In addition to the potential clinical benefit of improving decarboxylation efficiency in Parkinson's disease, our approach may be relevant for the treatment of AADC deficiency, a rare, autosomal recessive disorder causing a severe movement disorder and progressive cognitive impairment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11592835     DOI: 10.1006/mthe.2001.0466

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  30 in total

1.  Do hematopoietic cells exposed to a neurogenic environment mimic properties of endogenous neural precursors?

Authors:  P Walczak; N Chen; J E Hudson; A E Willing; S N Garbuzova-Davis; S Song; P R Sanberg; J Sanchez-Ramos; P C Bickford; T Zigova
Journal:  J Neurosci Res       Date:  2004-04-15       Impact factor: 4.164

2.  Human/nonhuman primate AC-PC ratio--considerations for translational brain measurements.

Authors:  Massimo S Fiandaca; Ernesto Aguilar Salegio; Dali Yin; R Mark Richardson; Francisco E Valles; Paul S Larson; Philip A Starr; Russell R Lonser; Krystof S Bankiewicz
Journal:  J Neurosci Methods       Date:  2010-12-24       Impact factor: 2.390

Review 3.  Adeno-associated virus vectors: potential applications for cancer gene therapy.

Authors:  Chengwen Li; Dawn E Bowles; Terry van Dyke; Richard Jude Samulski
Journal:  Cancer Gene Ther       Date:  2005-12       Impact factor: 5.987

4.  Real-time MR imaging of adeno-associated viral vector delivery to the primate brain.

Authors:  Massimo S Fiandaca; Vanja Varenika; Jamie Eberling; Tracy McKnight; John Bringas; Phillip Pivirotto; Janine Beyer; Piotr Hadaczek; William Bowers; John Park; Howard Federoff; John Forsayeth; Krystof S Bankiewicz
Journal:  Neuroimage       Date:  2008-11-27       Impact factor: 6.556

5.  Safety and tolerability of magnetic resonance imaging-guided convection-enhanced delivery of AAV2-hAADC with a novel delivery platform in nonhuman primate striatum.

Authors:  Waldy San Sebastian; R Mark Richardson; Adrian P Kells; Clementine Lamarre; John Bringas; Philip Pivirotto; Ernesto A Salegio; Stephen J Dearmond; John Forsayeth; Krystof S Bankiewicz
Journal:  Hum Gene Ther       Date:  2012-01-26       Impact factor: 5.695

6.  Focal striatal dopamine may potentiate dyskinesias in parkinsonian monkeys.

Authors:  Krystof S Bankiewicz; Marcel Daadi; Philip Pivirotto; John Bringas; Laura Sanftner; Janet Cunningham; John R Forsayeth; Jamie L Eberling
Journal:  Exp Neurol       Date:  2005-12-09       Impact factor: 5.330

Review 7.  Therapeutic gene transfer to the nervous system using viral vectors.

Authors:  Joseph C Glorioso; Marina Mata; David J Fink
Journal:  J Neurovirol       Date:  2003-04       Impact factor: 2.643

8.  Lack of humoral immune response to the tetracycline (Tet) activator in rats injected intracranially with Tet-off rAAV vectors.

Authors:  Y Han; Q A Chang; T Virag; N C West; D George; M G Castro; M C Bohn
Journal:  Gene Ther       Date:  2010-02-18       Impact factor: 5.250

9.  Biodistribution of adeno-associated virus type-2 in nonhuman primates after convection-enhanced delivery to brain.

Authors:  Janet Cunningham; Philip Pivirotto; John Bringas; Brian Suzuki; Sharmila Vijay; Laura Sanftner; Marina Kitamura; Curtis Chan; Krystof S Bankiewicz
Journal:  Mol Ther       Date:  2008-06-03       Impact factor: 11.454

10.  Safety and tolerability of putaminal AADC gene therapy for Parkinson disease.

Authors:  C W Christine; P A Starr; P S Larson; J L Eberling; W J Jagust; R A Hawkins; H F VanBrocklin; J F Wright; K S Bankiewicz; M J Aminoff
Journal:  Neurology       Date:  2009-10-14       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.